Future Scenarios and Implications for the Pacemakers Industry: Medico S.p.A., Vitatron, Abbott, Medtronic, OSCOR, LivaNova Plc, Boston Scientific Corporation, Biotronik, Pacetronix, and Lepu Medical

The global pacemakers market accounted to US$ 5,485.4 Mn in 2018 and is expected to grow at a CAGR of 8.1% during the forecast period 2019 - 2027, to account to US$ 10,908.0 Mn by 2027.

Product launches and agreements were observed as the most adopted strategy in global pacemakers industry. For instance, in February 2017, Abbott announced US Food and Drug Administration (FDA) approval for its Assurity MRI pacemaker and Tendril MRI pacing lead. The Assurity MRI pacemaker also offers wireless remote monitoring, providing physicians secure access to their patients' diagnostic data and daily device measurements and reducing the need for in-office visits. Moroever, in April 2018, LivaNova Plc completed its sale of cardiac rhythm management business to microport scientific corporation.

Get sample PDF copy: https://www.theinsightpartners.com/sample/TIPHE100000884/?opr-ss

The growth in the region is driven by the key factors such as rapid growth of medical device industries, emergence of new local players with competitive scenario among the regional players with respect to developing novel solutions

Leading Players: Medico S.p.A., Vitatron, Abbott, Medtronic, OSCOR, LivaNova Plc, Boston Scientific Corporation, Biotronik, Pacetronix, and Lepu Medical

Increasing Burden of Cardiovascular Diseases

The increasing technological advancements have opened more opportunities of developing new and innovative medical implantable pacemakers with advanced electrical properties that can improve diagnosis and treatment of previously intractable conditions such as, cardiovascular diseases that includes cardiac arrhythmia, atrial fibrillation and others. A pacemaker is an electronic device designed to produce electrical impulses to stimulate the heart when normal physiological stimulation fails. In 2017, according to the World health organization, the increasing prevalence of cardiovascular diseases is the major cause of death all over the world. Moreover, it was mentioned that 17.9 million people across the globe died due to cardiovascular diseases in 2016. Cardiovascular disease is one of the leading causes of morbidity and mortality and is responsible for 30% of worldwide mortality, according to the World Health Organization.

Buy the complete report @ https://www.theinsightpartners.com/buy/TIPHE100000884/?opr-ss

Reason to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the pacemakers market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the global pacemakers market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com
Web: https://www.theinsightpartners.com/

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

This release was published on openPR.